Forskning

Timing of HT found key to its risks and benefits

by Doug Brunk FROM THE ANNUAL MEETING OF THE ENDOCRINE SOCIETY SAN DIEGO -- The scale that weighs risks and benefits tips more favorably for newly menopausal women who begin hormone therapy at age 50-59 years and who use it for 5 years, compared with women who start the therapy in their 60s,... Read More

Primary Prevention of Cardiovascular Disease With HRT

Kate Maclaran; John C Stevenson Authors and Disclosures Posted: 01/03/2012; Women's Health. 2012;8(1):63-74. © 2012 Future Medicine Ltd. Abstract Prevention of cardiovascular disease has increasingly important health implications as our population ages. Menopause is associated with the... Read More

Estrogen Alone Is Effective for Reducing Breast Cancer Risk, Study Finds

ScienceDaily (Dec. 9, 2010) While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact, hormone replacement therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer... Read More

HRT and breast cancer risk: a realistic perspective

December 2011, Vol. 14, No. 6 , Pages 633-636 (doi:10.3109/13697137.2011.590618) Read More:... Read More

New Views Of Hormone Therapy in Menopause

Wall Street Journal SEPTEMBER 27, 2011 The 25 million American women turning 50 in the next decade face a vexing decision: Hormone replacement therapy? Or not. There's still no simple answer. For years, estrogen was seen as a fountain of youth that would keep women healthy and sexy long after... Read More